Medical Condition News

RSS

Investigating incidence and clinical features of post-acute sequelae of COVID-19 in children and adolescents

Researchers identify symptoms and systematic conditions associated with PASC in children

30 May 2022

Medical cannabis use shown to improve cancer-related symptoms in new study

Researchers describe the effectiveness and safety of medical cannabis use for treating cancer-related symptoms.

30 May 2022

Increase in depression and anxiety rates in the U.K. identified during COVID-19 lockdowns

Researchers discuss changes in depressive and anxiety symptoms during the COVID-19 pandemic.

30 May 2022

Study finds long-term exposure to common air pollutants is associated with COVID-19 severity

Researchers evaluate the relationship between long-term exposure to three common air pollutants and key indicators of COVID-19 severity.

30 May 2022

Neurological symptoms may persist for over one year in long-COVID patients

Patients who have recovered from COVID-19 are likely to experience persistent neurologic symptoms for a median of 14.8 months following their initial infection.

30 May 2022

Scientists determine trajectory and pathophysiology of post-COVID-19 syndrome

A new study utilizes multisystem imaging, along with biomarker analysis, to better understand the pathogenesis of COVID-19.

30 May 2022

New virtual biopsy could lead to major improvements in care for heart transplant patients

The days of heart transplant survivors undergoing invasive biopsies could soon be over after a new MRI technique has proven to be safe and effective; reducing complications and hospital admissions.

29 May 2022

Adolescent smoking is a transmissible habit, finds UK study

A new preprint paper exposes the risk factors behind the uptake of smoking in adolescence, which is among the factors that best predict adult smoking.

28 May 2022

Scientists identify core factors that may put Long QT patients at higher risk of sudden cardiac death

Less than 1 percent of the population has been diagnosed with Long QT syndrome – a rare heart condition that can cause chaotic, sometimes fatal, heart rhythms.

27 May 2022

Autistic adults have worse health and poorer quality healthcare

Autistic individuals are more likely to have chronic mental and physical health conditions, suggests new research from the University of Cambridge. Autistic individuals also report lower quality healthcare than others.

27 May 2022

National cancer care spending has no link to population-level cancer mortality rates

While the U.S. spends twice as much on cancer care as the average high-income country, its cancer mortality rates are only slightly better than average, according to a new analysis by researchers at Yale University and Vassar College.

27 May 2022

New approach could treat brain tumors and also prevent or delay recurrences

Scientists at the University of Michigan Rogel Cancer Center were optimistic when they identified a small molecule that blocked a key pathway in brain tumors.

27 May 2022

Study evaluates diagnostic performance of two blood-based biomarkers specific to Alzheimer's disease

A simple blood test to diagnose Alzheimer's disease, perhaps even years before symptoms appear, is an exciting possibility, but a new study shows that much more research is needed before these blood tests are routinely used in the clinical diagnostic setting.

26 May 2022

Sarcopenic obesity independently associated with an increased prevalence of dementia

Obesity, an increasingly prevalent lifestyle disease, often occurs along with poor muscle mass. This condition, called sarcopenic obesity, is evaluated based on the patients' body mass index (BMI) and handgrip strength.

26 May 2022

Scientists unlock a new approach to kill hard-to-treat cancers

In a paper appearing in Nature today, an international group of scientists have unlocked a new way to kill hard to treat cancers. These tumors resist current immunotherapies, including those using Nobel Prize winning check-point blocking antibodies.

26 May 2022

Risk factors for COVID-19 in patients with hematological malignancies

Researchers investigate the risk factors present in individuals suffering from hematological malignancies and COVID-19.

26 May 2022

HMA therapy for patients with myelodysplastic syndrome could potentially activate a sleeping oncogene

Hypomethylating agents (HMA) are currently used as a first-line treatment for patients with myelodysplastic syndrome (MDS) - a group of disorders where there is insufficient production of healthy mature blood cells in the bone marrow - and increasingly in other diseases, but their mechanism of action remains unclear.

26 May 2022

Medical Condition News

Investigating incidence and clinical features of post-acute sequelae of COVID-19 in children and adolescents

Medical cannabis use shown to improve cancer-related symptoms in new study

Increase in depression and anxiety rates in the U.K. identified during COVID-19 lockdowns

Study finds long-term exposure to common air pollutants is associated with COVID-19 severity

Neurological symptoms may persist for over one year in long-COVID patients

Scientists determine trajectory and pathophysiology of post-COVID-19 syndrome

New virtual biopsy could lead to major improvements in care for heart transplant patients

Adolescent smoking is a transmissible habit, finds UK study

Scientists identify core factors that may put Long QT patients at higher risk of sudden cardiac death

Autistic adults have worse health and poorer quality healthcare

National cancer care spending has no link to population-level cancer mortality rates

New approach could treat brain tumors and also prevent or delay recurrences

Study evaluates diagnostic performance of two blood-based biomarkers specific to Alzheimer's disease

Sarcopenic obesity independently associated with an increased prevalence of dementia

Scientists unlock a new approach to kill hard-to-treat cancers

Risk factors for COVID-19 in patients with hematological malignancies

HMA therapy for patients with myelodysplastic syndrome could potentially activate a sleeping oncogene

Aston University’s new antibiotic combination forms part of a lifesaving treatment for cystic fibrosis

Multidisciplinary care improves outcomes from chronic kidney disease

New biomarker may enable rapid, inexpensive diagnosis of Parkinson's disease

Obesity, GLP-1s, and metabolic care

Automation in cell-based workflows

Data management challenges in scientific research

Latest News